Interestingly, plasma levels of the alternative inflammatory biomarker LPS binding protein (LBP) were found to be consistently lower in PD patients than in healthy patients (Forsyth et al., 2011; Pal et al., 2015; Chen et al., 2021). This evidence concerns the gene LBP and Parkinson disease.